Use Patterns and Unlabeled Uses of Target-Specific Oral Anticoagulants: A Single-Center Experience.

about

Use Patterns and Unlabeled Uses of Target-Specific Oral Anticoagulants: A Single-Center Experience.

Item

http://www.wikidata.org/entity/Q55220400

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Use Patterns and Unlabeled Use ...... s: A Single-Center Experience.

@en

Use Patterns and Unlabeled Use ...... s: A Single-Center Experience.

@nl

type

Item

label

Use Patterns and Unlabeled Use ...... s: A Single-Center Experience.

@en

Use Patterns and Unlabeled Use ...... s: A Single-Center Experience.

@nl

prefLabel

Use Patterns and Unlabeled Use ...... s: A Single-Center Experience.

@en

Use Patterns and Unlabeled Use ...... s: A Single-Center Experience.

@nl

P1476

Use Patterns and Unlabeled Use ...... ts: A Single-Center Experience

@en

P2093

Jaekyu Shin

http://www.w3.org/2001/XMLSchema#string

Lynn V. Do

http://www.w3.org/2001/XMLSchema#string

Shin-Yi Lin

http://www.w3.org/2001/XMLSchema#string

Steve R. Kayser

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran versus warfarin in patients with mechanical heart valves

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.

Glomerular filtration rate equations overestimate creatinine clearance in older individuals enrolled in the Baltimore Longitudinal Study on Aging: impact on renal drug dosing.

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.

New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function.

Assessment of dabigatran utilization and prescribing patterns for atrial fibrillation in a physician group practice setting.

P304

204-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/8755122515578009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

anticoagulation

P932

5990191

http://www.w3.org/2001/XMLSchema#string